Immunogenicity and Safety of Adacel Polio Vaccine
NCT00797511
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Diphtheria
Tetanus
Pertussis
Poliomyelitis
Interventions
BIOLOGICAL:
TdcP-IPV vaccine
Sponsor
Sanofi